Sign In
Section Navigation
Common Title08-2070
Official Title Antiretroviral Activity and Tolerability of Once Daily Etravirine in Treatment-Naïve Adults With HIV-1 Infection
Phase Phase II
ClinicalTrials.gov NCT00959894
Categories Treatment-Naive
Funding
IndustryJanssen
References
  • Floris-Moore MA, Mollan K, Wilkin AM, et al. Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results. Antivir Ther. 2016;21:55-64.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.